Ruian Wanjiang Auto Parts Co.,Ltd , https://www.wanjiangautoparts.com
It is understood that this time a total of 4138 samples were examined for drugs, of which 85 were unqualified; 45 medical instruments were spot-checked and 2 were unqualified; 133 pieces of drug packaging material were sampled and 19 were unqualified.
The unqualified drugs also include Methylcobalamin Tablets manufactured by Jiangsu Sihuan Biological Co., Ltd. with lot number 0803181; Hepatic Hydrolyzed Peptide Injection Batch No. 061201 produced by Huinan Huifa Pharmaceutical Co., Ltd. of Jilin Province; Wuhu Sanyi Pharmaceuticals Co., Ltd. production of batch 080401 tetracycline acetate cortisone hydrochloride ointment; Guangdong Province Bo Luo Pioneer Pharmaceutical Group Co., Ltd. production lot number 070901 of Acanthopanax; Surabaya Hillcom Pharmaceutical Co., Ltd. production lot number 0708161 Dexamethasone Sodium Phosphate Injection; Gliclazide Sustained Release Batch No. 070701 produced by Yantai Chuchu Pharmaceutical Co., Ltd.; Xanthium Rhinitis Capsule Batch No. 20071203 produced by Changchun Overseas Pharmaceutical Group Co., Ltd.; Changchun Silver Ning Ke Pharmaceutical Co., Ltd. production of batch number 20060902 ç—” speed ning film.
Shanghai Food and Drug Administration detected unqualified vitamin C silver fins
Yesterday, the Shanghai Food and Drug Administration announced the announcement of the unqualified sample inspection during the third quarter of 2008. Among them, batch No. 080107 was produced by Wei Ning Weiwei Pharmaceutical Co., Ltd.; Batch No. 080202, commonly used drugs such as Tracheitis Pills produced by Hebei Wansian Pharmaceutical Co., Ltd. were unqualified.